AtriCure, Inc. (ATRC): Price and Financial Metrics


AtriCure, Inc. (ATRC): $45.03

0.96 (+2.18%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ATRC POWR Grades

  • ATRC scores best on the Stability dimension, with a Stability rank ahead of 50.6% of US stocks.
  • The strongest trend for ATRC is in Stability, which has been heading down over the past 179 days.
  • ATRC's current lowest rank is in the Growth metric (where it is better than 16.03% of US stocks).

ATRC Stock Summary

  • ATRC's current price/earnings ratio is 37.27, which is higher than 84.05% of US stocks with positive earnings.
  • ATRC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 16.53% of US stocks.
  • Over the past twelve months, ATRC has reported earnings growth of -212.56%, putting it ahead of merely 7.83% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to ATRICURE INC, a group of peers worth examining would be JMIA, ISPC, RMO, VAPO, and POSH.
  • ATRC's SEC filings can be seen here. And to visit ATRICURE INC's official web site, go to www.atricure.com.

ATRC Valuation Summary

  • ATRC's price/sales ratio is 6.6; this is 24.53% higher than that of the median Healthcare stock.
  • Over the past 208 months, ATRC's price/sales ratio has gone down 9.5.

Below are key valuation metrics over time for ATRC.

Stock Date P/S P/B P/E EV/EBIT
ATRC 2022-09-01 6.6 4.4 37.5 34.7
ATRC 2022-08-31 7.0 4.6 39.7 36.8
ATRC 2022-08-30 7.0 4.6 39.8 36.8
ATRC 2022-08-29 7.0 4.7 39.9 37.0
ATRC 2022-08-26 7.2 4.8 40.9 37.9
ATRC 2022-08-25 7.6 5.0 43.0 39.7

ATRC Growth Metrics

    Its 3 year cash and equivalents growth rate is now at 35.82%.
  • The 4 year cash and equivalents growth rate now stands at 35.13%.
  • Its 4 year net cashflow from operations growth rate is now at 7.52%.
Over the past 67 months, ATRC's revenue has gone up $139,815,000.

The table below shows ATRC's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-03-31 289.63 -29.096 51.933
2021-12-31 274.329 -13.78 50.199
2021-09-30 258.836 -10.127 45.378
2021-06-30 243.133 -6.083 -56.679
2021-03-31 212.581 -13.098 -48.664
2020-12-31 206.531 -19.869 -48.155

ATRC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ATRC has a Quality Grade of C, ranking ahead of 28.8% of graded US stocks.
  • ATRC's asset turnover comes in at 0.344 -- ranking 124th of 186 Medical Equipment stocks.
  • INGN, BSX, and GKOS are the stocks whose asset turnover ratios are most correlated with ATRC.

The table below shows ATRC's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.344 0.746 -0.169
2021-03-31 0.301 0.729 -0.142
2020-12-31 0.311 0.723 -0.152
2020-09-30 0.337 0.722 -0.163
2020-06-30 0.361 0.722 -0.213
2020-03-31 0.463 0.736 -0.227

ATRC Price Target

For more insight on analysts targets of ATRC, see our ATRC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $96.71 Average Broker Recommendation 1.31 (Strong Buy)

ATRC Stock Price Chart Interactive Chart >

Price chart for ATRC

ATRC Price/Volume Stats

Current price $45.03 52-week high $89.18
Prev. close $44.07 52-week low $32.83
Day low $43.37 Volume 25,380
Day high $45.28 Avg. volume 262,826
50-day MA $46.51 Dividend yield N/A
200-day MA $55.75 Market Cap 2.09B

AtriCure, Inc. (ATRC) Company Bio


Atricure provides atrial fibrillation solutions worldwide. The Company has three primary product lines for cardiac tissue ablation and a product line for left atrial appendage exclusion. The company was founded in 2000 and is based in West Chester, Ohio.


ATRC Latest News Stream


Event/Time News Detail
Loading, please wait...

ATRC Latest Social Stream


Loading social stream, please wait...

View Full ATRC Social Stream

Latest ATRC News From Around the Web

Below are the latest news stories about ATRICURE INC that investors may wish to consider to help them evaluate ATRC as an investment opportunity.

AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

MASON, Ohio, August 16, 2022--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference.

Yahoo | August 16, 2022

AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates

AtriCure (ATRC) delivered earnings and revenue surprises of -6.67% and 6.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 2, 2022

AtriCure Reports Second Quarter 2022 Financial Results

MASON, Ohio, August 02, 2022--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced second quarter 2022 financial results.

Yahoo | August 2, 2022

Is AtriCure (NASDAQ:ATRC) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Yahoo | August 2, 2022

Top 10 Stock Picks of Efrem Kamen’s Pura Vida Investments

In this article, we shall be going through the top 10 stock picks of Efrem Kamen’s Pura Vida Investments. To skip our detailed analysis of Kamen’s history, his investment strategy, and hedge fund performance, go directly and see Top 5 Stock Picks of Efrem Kamen’s Pura Vida Investments. Efrem Kamen currently serves as Managing Member […]

Yahoo | July 28, 2022

Read More 'ATRC' Stories Here

ATRC Price Returns

1-mo -7.95%
3-mo 15.88%
6-mo -24.57%
1-year -41.61%
3-year 87.70%
5-year 122.26%
YTD -35.24%
2021 24.90%
2020 71.24%
2019 6.24%
2018 67.76%
2017 -6.80%

Continue Researching ATRC

Here are a few links from around the web to help you further your research on AtriCure Inc's stock as an investment opportunity:

AtriCure Inc (ATRC) Stock Price | Nasdaq
AtriCure Inc (ATRC) Stock Quote, History and News - Yahoo Finance
AtriCure Inc (ATRC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6929 seconds.